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PEMBANGUNAN DAN PENILAIAN UJIAN TINDAK BALAS RANTAIAN 
POLIMERASE MULTIPLEKS YANG STABIL SUHU BAGI PENGESANAN 
SERENTAK Klebsiella pneumoniae DAN Haemophilus influenzae 
 
ABSTRAK 
Klebsiella pneumoniae dan Haemophilus influenzae adalah patogen penting yang 
berkaitan dengan pelbagai jenis jangkitan seperti pneumonia, jangkitan saluran 
pernafasan, meningitis dan juga septisemia. Namun, pengesanan melalui kaedah 
pengkulturan mengambil masa yang lama, serta kurang sensitif. Tindak balas rantai 
polimerase (PCR) konvensional pula masih memerlukan penyimpanan sejuk dan 
kakitangan terlatih untuk melaksanakan ujian ini. Kajian ini bertujuan untuk 
membangun dan menilai PCR multipleks stabil suhu bagi pengesanan serentak K. 
pneumoniae dan H. influenzae. Tiga set primer, terhadap gene php K. pneumoniae, 
p6 H. influenzae dan glmM Helicobacter pylori (kawalan dalaman) telah direka dan 
diuji di dalam kajian ini. Semua reagen PCR seperti enzim Taq polimerase DNA, 
MgCI2, dNTPs, 10 X larutan penampan dan primer telah dioptimumkan dan 
dikeringkan ke dalam bentuk pelet dengan menggunakan penstabil enzim (trehalose). 
Kepekatan penstabil enzim dan Taq polimerase DNA juga telah dioptimumkan untuk 
multipleks stabil PCR. Analisis sensitiviti telah dinilai di peringkat genomik dan 
bakteria. Manakala, analisis pengkhususan multipleks stabil suhu PCR kemudiannya 
dinilai dengan menggunakan 30 bakteria berbeza. Kestabilan multipleks PCR ini 
telah diuji pada tiga suhu yang berbeza (4°C, 25°C, dan 37°C). Hasil kajian 
menunjukkan bahawa kestabilan ujian PCR ini adalah optimum apabila kepekatan 
8% penstabil dan 200% Taq DNA polymerase digunakan. Had pengesanan (LOD) 
pada peringkat genomik untuk multipleks K. pneumoniae dan H. influenzae adalah 1 
xvi 
 
pg DNA. Sebaliknya, LOD pada peringkat bakteria multipleks PCR K. pneumoniae 
dan H. influenzae adalah pada 1 x 103 CFU / ml. PCR multipleks stabil suhu ini telah 
menunjukkan 100% tanpa amplifikasi bakteria lain. Berdasarkan ujian kestabilan, 
multipleks stabil suhu PCR dianggarkan stabil untuk sekurang-kurangnya 3.02 bulan 
pada suhu 25°C. PCR multipleks stabil suhu untuk mengesan K. pneumoniae dan H. 
influenzae adalah mudah, spesifik, senang untuk dilaksanakan, kos yang efektif dan 
mengurangkan masa penyediaan PCR reagen. Oleh sebab itu, ujian ini mempunyai 
potensi untuk digunakan dalam rutin diagnosis, hospital dan pelbagai bidang lain. 
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DEVELOPMENT AND EVALUATION OF THERMOSTABILIZED 
MULTIPLEX POLYMERASE CHAIN REACTION FOR SIMULTANEOUS 
DETECTION OF Klebsiella pneumoniae AND Haemophilus influenzae 
 
ABSTRACT 
 
Klebsiella pneumoniae and Haemophilus influenzae are important pathogens 
associated with the various types of infections such as pneumonia, respiratory tract 
infections, meningitis and also septicemia. The identification of these pathogens 
using culture methods are time-consuming, and insensitive, while conventional 
polymerase chain reaction (PCR) still require cold-chain storage and trained 
personnel to perform the assay. Thus, the aim of this study is to develop and evaluate 
the thermostabilized multiplex PCR for simultaneous detection of K. pneumoniae 
and H. influenzae. Three sets of primer, php gene of K. pneumoniae, p6 gene of H. 
influenzae and glmM gene of Helicobacter pylori (internal control) were designed 
and optimized in this study. All PCR reagents such as Taq DNA polymerase, MgCI2, 
dNTPs, 10 X buffer and primers were optimized and lyophilized into a pellet form 
with an enzyme stabilizer (trehalose). The concentrations of enzyme stabilizer and 
Taq DNA polymerase were optimized for thermostabilized multiplex PCR.  The 
analytical sensitivity of the assay was evaluated both at the genomic and bacteria 
levels. While, the analytical specificity of thermostabilized multiplex PCR was 
evaluated using 30 different bacteria. The stability of thermostabilized multiplex 
PCR was determine using accelerated stability test at three different temperatures 
(4°C, 25°C, and 37°C). The results showed that thermostabillized PCR was stable at 
the concentrations of 8% stabilizer and 200% Taq DNA polymerase. The limit of 
xviii 
 
detection (LOD) at genomic level for multiplex K. pneumoniae and H. influenzae 
was 1 pg of DNA. On the other hand, the LOD at bacterial level multiplex PCR of K. 
pneumoniae and H. influenzae was 1 x 103 CFU/ ml. The thermostabilized multiplex 
PCRs demonstrated specificity of 100% with no amplification was observed with 
other bacteria strains.  Based on the stability tests, the thermostabilized multiplex 
PCR was estimated to be stable for at least 3.02 months at 25°C. The 
thermostabilized multiplex PCR for detection of K. pneumoniae and H. influenzae is 
simple, specific, easy to perform, cost-effective and minimize the preparation time of 
PCR mixture. Hence, this assay has potential to be used in routine diagnosis, hospital 
settings and fields. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 Background of studies 
Klebsiella pneumoniae and Haemophilus influenzae are classified under Gram 
negative bacteria which commonly colonize the human respiratory tract, especially in 
the nasopharynx and become part of normal respiratory flora (Kofteridis et al., 2009; 
Farida et al., 2013). Both pathogens are important and can lead to various types of 
healthcare associated infections such as pneumonia, respiratory tract infections 
(RTIs), meningitis and also blood stream infections (CDC, 2012). Most infections of 
H. influenzae come from direct extension of the nasopharynx to the lower respiratory 
tract. On the other hand, the infections of K. pneumoniae are usually found in the 
lung (pneumonia) and blood (bacteremia) (Custovic et al., 2014). 
 
 Respiratory diseases, especially RTIs are the main causes of mortality and 
morbidity around the world. RTIs become the main public health concern affecting 
both children and adults particularly the lower respiratory tract infections (LRTIs) in 
both developing and developed countries (Boloursaz et al., 2013; Ezeonwu et al., 
2014). It has been reported that the microbiological causes for LRTIs are bacterial 
pathogens such as K. pneumoniae and H. influenzae (Ramana et al., 2013). Both 
pathogens were also reported to cause diseases during the Hajj season (Mansouri et 
al., 2012; Gautret et al., 2016). Community-acquired pneumonia (CAP) becomes one 
of the common LRTIs with high morbidity and mortality. H. influenzae was reported 
as the second most important bacterial pathogen of pneumonia and meningitis after 
Streptococcus pneumoniae (Boloursaz et al., 2013). In addition, RTIs serves as a 
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major contributor among intensive care unit (ICU) patients and the common 
pathogens that affect them are K. pneumoniae followed by Proteus mirabilis and 
Pseudomonas aeruginosa (Custovic et al., 2014). Another study showed that K. 
pneumoniae is the prevalent etiological agent which leads to pneumonia after S. 
pneumoniae (Farida et al., 2013).  
 
1.1.1 Klebsiella pneumoniae 
K. pneumoniae is classified under Klebsiella genus of Enterobacteriaceae and exist in 
the soil and in water as free living microorganisms (Kowalski, 2012). It is commonly 
considered as an opportunistic pathogen and can be asymptomatically found in the 
intestinal and respiratory tracts and skin of healthy individual but can also give 
infection in hospitalized patients (Holt et al., 2015). K. pneumoniae is responsible for 
the majority of infections in human followed by K. oxytoca, K. ozaenae and K. 
rhinoscleromatis (Caputo et al., 2015).  
 
This pathogen is the common source of community and hospital-acquired 
infections, especially in respiratory tract and bloodstream infections. K. pneumoniae 
has been reported as an important cause of hospital-acquired infections, especially 
among patients in the neonatal ICU and mortality rates can be as high as 70%. 
(Gupta et al., 2003). Moreover, the importance of K. pneumoniae as an invasive 
pathogen seems to be increasing due to the emergence and progressive spread of 
multi drug resistance specifically extended-spectrum β-lactamase (ESBL) 
(Meatherall et al., 2009; Chandel et al., 2011). 
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1.1.1.1 Morphology 
This Gram negative rod shaped bacterium is facultative anaerobes, non-motile and 
belongs to the normal flora of the intestines, mouth and skin. This species exhibits 
mucoid growth, size range from 0.3 to 1.0 mm in width and 0.6 to 6.0 mm in length 
and usually gives positive tests for lysine decarboxylase and citrate. This bacterium 
is surrounded by a capsule, which acts as a physical barrier to evade the host of 
immune response. 
 
1.1.1.2 Taxonomic Classification 
Listed below is the hierarchy taxonomic classification for K. pneumoniae. 
Kingdom : Bacteria 
Phylum : Proteobacteria 
Class  : Gammaproteobacteria 
Order  : Enterobacteriales 
Family  : Enterobacteriaceae 
Genus  : Klebsiella 
Species : K. pneumoniae 
 
1.1.2 Haemophilus influenzae 
Haemophilus influenzae which is also known as Pfeiffer’s bacillus was described in 
1892. Pfeiffer found an association between the sputum of patient and the clinical 
syndrome that causes influenza during the outbreak. The influenza was confirmed as 
H. influenzae and it was found to cause the secondary infection in 1933 (CDC, 
2015). This pathogen is widely spread among human. The human upper respiratory 
tracts are known as the reservoir of various communities of commensal pathogens 
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like H. influenzae and the colonization of this bacterium in the nasopharynx 
occasionally results in diseases. H. influenzae are opportunistic pathogens in which 
they live in the host without causing diseases. However, they will take advantage 
when other factors such as viral infection are present (Sydnor and Perl, 2011). 
Usually, non-typeable H. influenzae (NTHi) is harbored as a normal flora. However, 
a minority of healthy individuals may accidentally be exposed to the colonization of 
H. influenzae type b (Hib) strains in the upper respiratory tract (Clementi and 
Murphy, 2011). 
 
Some strains of H. influenzae possess a polysaccharide capsule representing 
the major virulence factor and antigen of this bacterial species (Ulanova, 2013). 
There are six capsular serotypes (a-f) of H. influenzae, in which serotype b is the 
most common pathogen for invasive diseases. The infection cause by this type can 
lead to meningitis, pneumonia, epiglottitis, bacteremia and cellulitis (CDC, 2014). 
However, due to the emergence and successful implementation of Hib vaccination 
program, serotype b become low and serotype a is increasingly found to cause 
invasive infections. Moreover, serotype f also emerged as a cause of invasive 
infections but is less common than serotype a (Ulanova, 2013). H. influenzae that 
lack capsular polysaccharides is known as non-typeable H. influenzae. NTHi is 
commonly present as the normal flora of the upper respiratory tract, less invasive and 
is an uncommon cause of opportunistic RTIs (Kaneko et al., 2014). Nevertheless, it 
is one of the top causes of respiratory infections in human causing acute otitis media 
(AOM), bronchitis, chronic obstructive pulmonary disease (COPD) (Apisarnthanarak 
and Mundy, 2005).  
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1.1.2.1 Morphology 
H. influenzae is a rod-shaped, non-motile and facultative anaerobe bacteria. This 
bacteria grown on chocolate agar at 37°C in an enriched CO2 incubator and requires 
two growth factors which are factor X (haemin) and V factor (NAD). The colony of 
this pathogen looks like convex, smooth, pale and grey colour. Gram-stained shows 
Gram-negative coccobacilli with no specific arrangement. 
 
1.1.2.2 Taxonomic Classification 
Listed below is the hierarchy taxonomic classification for H. influenzae. 
Kingdom : Bacteria 
Phylum : Proteobacteria 
Class  : Gammaproteobacteria 
Order  : Pasteurellales 
Family  : Pasteurellaceae 
Genus  : Haemophilus 
Species : H.influenzae 
 
1.2   Epidemiology 
The aetiological bacteria of RTIs are different in developed and developing 
countries. Pneumonia is stated as one of the main causes of death among newborn 
infants. Approximately 922,000 deaths in children were estimated due to pneumonia 
in 2015 (WHO, 2015). The significant pathogens associated with pneumonia in the 
developed countries are S. pneumoniae, Mycoplasma pneumoniae, and H. influenzae. 
However, the implemented of pneumococcal vaccination program decrease the rates 
of pneumonia among children in the United States (Boloursaz et al., 2013). In 
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contrast, 1.9 million children died from respiratory infections all over the world 
especially in Southeast Asia and Africa (WHO, 2009). CAP was reported as the 
major cause of adult mortality in Asian countries (Peto et al., 2014). S. pneumoniae, 
Burkholderia pseudomallei and H. influenzae were the most common pathogens 
reported in Cambodia during the period of 1995 to 2012 (Goyet et al., 2014). 
Moreover, K. pneumoniae was particularly detected in CAP in Thai adults and 
Cambodian children. India (53.9%) was the largest contributor of etiologic pathogens 
associated with the hospital acquired pneumonia (HAP). However, Pakistan (55%) 
and China (41%) were the major contributors to the ventilator associated pneumonia 
(VAP) (Chawla, 2008).   
 
According to the Department of Statistics Malaysia (DOSM), pneumonia is 
one of the top five causes of death in Malaysia. In 2009, pneumonia was the 4th 
leading cause of death in the Ministry of Health (MOH) Hospitals in Malaysia 
(10.4% of hospital mortality) while respiratory disease was the 3rd leading cause of 
hospitalization (MOH, 2010). RTIs significantly cause morbidity and mortality 
especially in low income countries. Children are susceptible to infections by various 
pathogens. Therefore, clinicians may face difficulties in determining the causative 
pathogen that infects them. The amount of studies conducted to determine the 
aetiology of LRTI among children is still limited. Despite the widespread vaccination 
program especially against Hib, children are still susceptible to the risk of severe 
lung infections (Nathan et al., 2014). Approximately, thirty percent of patients visit 
to private and governments’ clinic in Malaysia due to upper RTIs. On the other hand, 
a study conducted by Noor Shafina and co-workers (2015) showed that Escherichia 
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coli and K. pneumoniae are the most common pathogens in urinary tract infection 
(UTI) among children.  
 
Respiratory tract infections (RTIs) have recently become the leading cause of 
morbidity and mortality in several parts of the world. RTIs involve both upper and 
lower respiratory tracts, and trigger the production of various diseases. The World 
Health Organization (WHO, 2010) reported that the acute lower respiratory tract 
infections and influenza are among the top ten leading causes of death. Prior studies 
have shown that different bacterial pathogens infected and produced various 
diseases. Generally, pathogens reported and associated with RTIs were H. influenzae 
and K. pneumoniae (Benedetto and Sevieri, 2013; Ngekeng et al., 2015; Gadsby et 
al., 2015). Infection cause by these types of bacteria leads to the production of severe 
health problems, especially among young children and immunocompromised 
persons, including, but not limited to, bronchitis, common cold, meningitis, otitis 
media and pneumonia.  
 
The spread of RTIs is varies among different countries, perhaps due to 
differing cultures, geographical regions and health care systems (Zhang et al., 2014). 
More serious diseases usually come from developing countries such as China, 
Indonesia, Malaysia and India. H. influenzae and K. pneumoniae have been reported 
as etiological agents in respiratory infections, and have become the most common 
causes of community-acquired pneumonia in adults in Japan (Fukuyama et al., 
2014). Previous studies have reported that K. pneumoniae ranks as a high cause of 
pneumoniae in Malaysia and Cambodia (Loh et al., 2007; Rammaert et al., 2012). 
Nathan et al. (2014) demonstrated that a significant pathogen isolated from a 
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nasopharyngeal swab among young children having RTI was H. influenzae. 
Considering the global burden of H. influenzae, vaccination programmes have been 
integrated into national immunization since the year 2000. However, in spite of 
vaccination, children remain to encounter severe lung infections (Nathan et al., 
2014). A similar study that also support this finding states that Hib is a major cause 
of bacterial meningitis and pneumoniae in India, Thailand, Malaysia and Indonesia 
(Lolekha et al., 2000; Nur Erleena et al., 2008). Apart from pneumoniae, Rehana et 
al. (2015) demonstrate that K. pneumoniae also found as significant cause for 
meningitis patients in Kelantan, Malaysia. 
 
1.2.1 Klebsiella pneumoniae 
K. pneumoniae is spread worldwide and is present in human, animal and the 
environment including forest, soil and water (Podschun and Ullmann, 1998; Cabral, 
2010). The strains of K. pneumoniae are often opportunistic pathogens associated 
with RTIs and UTIs in hospitalized patients and compromised individuals (Cabral, 
2010; Clegg and Murphy, 2016). The risk of infection and carriage rates of K. 
pneumoniae increases along with the increase in the period of stay in a hospital 
(Podschun and Ullmann, 1998; Sydnor and Perl, 2011). The bacteremia, UTI and 
nosocomial pneumonia (NP) rates in ICU located in Malaysia are 8.9, 4.7 and 20.5 
per 1,000 patient-days, respectively. Notably, Acinetobacter species, K. pneumoniae, 
P. aeruginosa and MRSA were the predominant pathogens isolated from the 
nosocomial infection during these periods in the three ICU in Malaysia (Katherason 
et al., 2008). 
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K. pneumoniae is known as a significant cause of hospital-acquired and 
community-acquired infection, especially among patients in the neonatal ICU. It 
becomes a major problem to patients and public health as it is a major cause of death, 
higher morbidity in hospitalized patients and leads to the increase of emotional stress 
(WHO, 2002). Recent study showed that methicillin-resistant S. aureus (MRSA) and 
K. pneumoniae are the most common isolated organisms in the ICU patients in Egypt 
(Eida et al., 2015). On the other hand, hospital-acquired infections due to K. 
pneumoniae, P. aeruginosa and Acinetobacter baumannii were reported to be 
increasing in the USA (Peleg and Hooper, 2010). 
 
Most of community-acquired infections occur in developing countries. 
Community acquired infection is a common disease and has become a major source 
of morbidity and death worldwide especially in the elderly and those with chronic 
disease (Yoon, 2014). K. pneumoniae was reported as the most prevalent community 
acquired pathogen in Egypt (Magdy et al., 2013). It was also proven that this 
pathogen is involved in severe community acquired and nosocomial pneumoniae in 
Cambodia and Taiwan (Rammaert et al., 2011; Chuang et al., 2012). K. pneumoniae 
is also one of the causative agents of community-acquired meningitis and brain 
abscesses in Asia, largely in Taiwan (Ko et al., 2002). Rehana et al. (2014) found 
that coagulase negative Staphylococcus, Acinetobacter species, S. aureus, 
Streptococcus spp and K. pneumoniae are prevalent hospital associated pathogens 
and are the cause of meningitis in Kelantan. This pathogen was ranked as the top 
cause of adult pneumonia requiring hospitalization in Malaysia (Loh et al., 2007). 
The most frequent organism isolated in the sputum culture associated with 
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pneumoniae among Hajj pilgrims from Malaysia are H. influenzae (20.3%), K. 
pneumoniae (17.6%), S. pneumoniae (16.2%) and S. aureus (9.5%).  
 
Moreover, the increase of the colonization rates of K. pneumoniae appears to 
be associated with the use of antibiotics in comparison to the factor of length of stay 
in the hospital (Podschun and Ullmann, 1998; Sydnor and Perl, 2011).  Severe 
nosocomial and community acquired infections due to multidrug resistant bacteria 
lead to the difficulty in finding suitable antibiotics. Furthermore, the extensive usage 
of broad- spectrum antibiotics to treat patients has led to the emergence of multiple 
resistant strains and the development of multidrug- resistant strains which produce 
extended–spectrum beta-lactamase (ESBL) (Sikarwar and Batra, 2010). The 
extensive use of antibiotics has led to the development of ESBLs which provides 
resistance against antibiotics (Sheikh et al., 2015). Palasubramaniam et al. (2005) 
reported that the connection between ESBL K. pneumoniae with nosocomial 
outbreak in a paediatric oncology unit in a Malaysian public hospital may be due to 
the clonal spread of the organism or by the transfer of plasmids encoding ESBL 
genes. The stability of the plasmids encoding ESBL has led to the emergence of 
multiple resistant towards several classes of antibiotics. 
 
1.2.2 Haemophilus influenzae 
The most well-known strain of H. influenzae is the type b strain which is the leading 
cause of invasive bacterial disease in children before the introduction of the first 
licensed H. influenzae vaccine (Agrawal and Murphy, 2011; Price et al., 2015). H. 
influenzae type b is a leading cause of bacterial meningitis and pneumoniae 
especially in infants and young children (Thairu et al., 2014). Moreover, pneumoniae 
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caused by H. influenzae type b strain has been reported to be more common than 
meningitis. The rates of Hib remain higher in American Indian and Alaska Native 
children (MacNeil et al., 2011). Children infected by H. influenzae type b are among 
the responsible cases of bacterial meningitis admitted to University Malaya Medical 
Center (UMMC) (Nur Erleena et al., 2008). However, it was reported that Hib in 
Thailand, Malaysia, India and Vietnam have low incidence of infection compared to 
the Western countries (Lolekha et al., 2000). This finding was strengthened by Mc 
Neil (2015) who stated that H. influenzae type b contributes to a smaller proportion 
of bacterial meningitis in Malaysia. 
 
The extensive use of the H. influenzae type B vaccine has triggered a great 
reduction in the prevalence of clinical disease arising from type b H. influenzae 
infection (King, 2012). As a result, the proportion of nasopharyngeal colonization 
among children showed a decrease in rate (Xu et al., 2012). The epidemiological 
trends of Hib disease among children have since been shifted towards the increase of 
the disease among elderly and those with underlying conditions (Puig et al., 2014). 
In Malaysia, the immunization associated with pneumococcal and influenza vaccines 
and RSV monoclonal antibodies is not extensively practiced due to economic 
reasons. Therefore, children are at the risk of severe lung infections even though 
vaccination of H. influenzae type b (Hib) has been incorporated since year 2000 
(Nathan et al., 2014). Hib has overshadowed the implications of other serotypes 
of H. influenzae in the etiology of bacterial infections. Serological types of H. 
influenzae such Hia can also cause significant morbidity and mortality. The highest 
incidence rates have been reported among the native population in North American 
12 
  
Indian (Ulanova, 2012). Moreover, the increasing incidence of two other serotypes 
such as Hie and Hif has been reported in England (Ladhani et al., 2012). 
 
On the other hand, NTHi is the main cause of Haemophilus respiratory disease 
and is a common colonizer pathogen in the upper respiratory tract system in a 
healthy individual. NTHi can cause diseases such as sinusitis, otitis media, and cystic 
fibrosis in adults and sepsis in neonates (Foxwell et al., 1998; Kosikowska et al., 
2015). Recent study from Schutter (2011) reported that majority of the sample from 
H. influenzae was identified as NTHi. The introduction of immunization with 
conjugate vaccine among children has caused NTHi to become common in the UK. 
Diseases such as meningitis and septicaemia are observed in neonates. Notably, 
misidentification towards Haemophilus species brings a wider effect for clinical 
diagnosis and assessment of disease outcomes from antibiotics (Price et al., 2015) 
Thus, it is important to differentiate H. influenzae from other species. The common 
strains involved in community acquired respiratory infections are H. influenzae or S. 
pneumoniae which are usually more susceptible to antibiotics. 
 
1.3 Pathogenicity 
1.3.1 K. pneumoniae 
Pathogenicity refers to the ability of an organism to cause disease. The ability is 
characterized by the genetic component of the organism and their effects to the host. 
There are several pathogenicity factors that influence the ability of K. pneumoniae to 
cause diseases including pili, siderophores, capsule and cell surface 
lipopolysaccharides (LPS). Each of these factors plays specific roles in the 
pathogenesis and leads to the different types and modes of infection (Podschun and 
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Ullmann, 1998). Different patterns of virulence factors can be seen with the respect 
of the different infected sites and host defense (Podschun and Ullmann, 1998).  
 
Moreover, geographic differences have also been recognized in affecting the 
range of diseases caused by K. pneumoniae. Studies conducted by Ko et al. (2002) 
reported that different regions are infected by different diseases. In Taiwan, 
meningitis and liver abscess infected by K. pneumoniae are the major health 
problems. As a comparison, 28 cases in Taiwan and 25 cases in South Africa, 
accounting for 29% and 62% of all cases of community-acquired K. pneumoniae 
bacteremia in Taiwan and South Africa were reported. The prevalence of serotypes 
K1/K2 of this pathogen colonizing the intestinal tract was reported to contribute to 
invasive liver abscess in Taiwan and Singapore. Moreover, Malaysia is the third 
leading rank of serotypes K1/ K2 found in stool after China and Taiwan (Lin et al., 
2012). K. pneumoniae was not common found in United States, Australia, Europe 
and Argentina which only four cases of community-acquired K. pneumoniae 
pneumonia have been found in two years out of nine large hospitals (Ko et al., 2002). 
 
Listed below are several factors associated with pathogenicity of K. pneumoniae.  
 
1) Pili 
Pili, also known as fimbrae are non-flagellar and consist of polymeric 
globular protein subunits. Its main function is to attach the pathogens into the 
host cells (Vuotto et al., 2014).  
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2) Siderophores 
Iron is an important factor in bacterial growth. It functions as a redox catalyst 
in proteins participating in oxygen and electron transport processes. By 
increasing the intake of iron, the susceptibility towards K. pneumoniae 
infection will automatically increase (Podchun and Ullmann, 1998; Russo et 
al., 2014). 
 
3)  Capsule 
Capsule is important to the virulence of Klebsiella spp. (Schembri et al., 
2004). It contains complex acidic polysaccharide and can be categorized into 
77 serological types. The functions of capsular are to protect the bacterium 
from phagocytosis by polymorphonuclear granulocytes and avoids killing of 
the bacteria by bactericidal serum factors (Podschun and Ullmann, 1998; 
Ares et al., 2016). 
 
4)  Cell surface lipopolysaccharide (LPS) 
LPS is the most vital virulence factors of K. pneumoniae in triggering sepsis. 
LPS consists of lipid A, core and O-polysaccharide in order to attack 
complement-mediated killing.  
 
1.3.2 H. influenzae 
Pathogenicity of H. influenzae can be divided into two which are typeable (especially 
type b) and non-typeable forms. The typeable H. influenzae plays a role in systemic 
infection such as otitis media, pneumoniae and meningitis which involves self-
defense (Lolekha et al., 2000). The non-typeable form is usually associated with 
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respiratory diseases such as sinusitis and bronchitis (Kosikowska et al., 2015). This 
type of strain rarely causes diseases outside the respiratory tract and can be 
considered as primary mucosal pathogens. H. influenzae has evolved rapidly in order 
to evade the host defense system including the ability to invade into local tissues 
(King, 2012).  
 
Listed below are several factors associated with pathogenicity of H. influenzae. 
 
1) Fimbriae 
The function of fimbriae is to assist attachment to epithelial cells. 
 
2) Lipooligosaccharide 
It contributes to the invasion into many stages including producing inhibition 
of ciliary function and also loss or death of ciliary mucosal cell. It was 
claimed that lipooligosaccharide is present in non-capsulated strains 
(Pettigrew et al., 2002).   
 
3) Pili 
Pili cause agglutination of red blood cells and promote attachment to 
respiratory tract epithelial cells. They are present only on a small portion of 
NTHi strains (King, 2012).                  
 
4) Outer membrane protein (OMP) 
H. influenzae expresses between 10 to 20 OMPs and the combination of the 
expressed proteins varies between strains. OMP consists of porin proteins 
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which are P2, P5 and P6. P2 and P5 proteins facilitate the binding of bacteria 
to the mucus. P2 contributes to the virulence of H. influenzae type b, while P5 
is involved in the invasion of the mucosal epithelium (Clementi and Murphy, 
2011; Euba et al., 2015). 
 
1.4 Detection Methods 
Precise identification of microorganisms is vital for treatment of infection and better 
disease diagnosis. Different procedures are designed for identification and detection 
of microorganisms. Conventional methods such as Gram staining, culture and 
biochemical tests have become the gold standard for detection of bacteria. These 
methods rely on phenotypic identification of the causative organism and are effective 
towards the diagnosis of patients. In particular, culture methods use selective liquid 
or solid culture to grow, isolate and count the target bacteria (Jasson et al., 2010). 
Meanwhile, rapid methods for detection of microorganisms such as polymerase chain 
reactions (PCR) are used to increase the chances of detection. 
 
1.4.1 Conventional Methods 
1.4.1.1        Klebsiella pneumoniae 
1.4.1.1.1     Culture 
K. pneumoniae can be cultivated in many types of media such as nutrient agar, blood 
agar (BA) and MacConkey agar. Colonies appear mucoid, sometimes sticky with 3-4 
mm diameter.        
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1.4.1.1.2 Biochemical Tests 
1.4.1.1.2.1 Simmon Citrate Agar 
Simmon Citrate Agar is a medium to differentiate members of Enterobacteriaceae. 
Bacteria are able to utilize citrate as a carbon source and the enzyme citrase will 
hydrolyze citrate into oxaloacetic acid and acetic acid. The production of CO2 
changes the pH indicator to blue. 
1.4.1.1.2.2 Methyl Red 
This test is used to determine the acidity when an organism ferments glucose. The 
pH indicator (methyl red) is added into the culture broth. The red color is absent 
when the pH increases, indicating a negative result in which K. pneumoniae is 
present.   
1.4.1.1.2.3 Voges Proskauer (VP) 
This test is used to determine the presence of acetoin. It is primarily used to 
differentiate between E. coli (VP-negative) from the Klebsiella-Enterobacter groups 
(VP-positive). 
1.4.1.1.3 VITEX identification 
The identification process using a Vitex GN card is performed according to the 
guidelines of the manufacturer for ESBL detection.  
1.4.1.1.4 Antimicrobial susceptibility testing (AST) 
1.4.1.1.4.1 Disk diffusion test 
AST is performed using Clinical and Laboratory Standard Institute (CLSI) disc 
diffusion method (CLSI, 2012). Antibiotic discs are placed onto the surface of 
Mueller Hinton Agar (MHA) and the plate is incubated at 37°C for 18-24 hours. The 
antibiotics tested are imipenem, meropenem and doripenem.  
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1.4.1.1.4.2 Etest 
Minimum inhibitory concentration (MIC) can be determined by Etest strips which 
consist of gradient concentrations of antibiotics on a plastic strip. E-test strips are 
placed onto the surface of MHA and the plate is incubated at 37°C for 18-24 hours. 
The concentration is measured by examining the zone edge intersects of the plastic 
strip. 
 
1.4.1.2         Haemophilus influenzae 
1.4.1.2.1    Culture 
The typical detection of H. influenzae is performed by culture. Microbiological 
differentiation of this organism from other species depends on the colony 
morphology, haemin and NAD (X and V factors). The culture of H. influenzae is 
performed on chocolate agar plate at 37°C in CO2 enriched incubator. The colonies 
appear as smooth, pale, grey or transparent and convex in shape. Another method to 
identify H. influenzae is by inoculating it together with the S. aureus on BA. 
Staphylococcus produces the necessary blood factor essential for the growth of H. 
influenzae. Smaller colonies representing H. influenzae will grow around S. aureus 
(WHO, 2003). 
1.4.1.2.2       Biochemical Tests 
1.4.1.2.2.1 X and V factors 
A single colony of H. influenzae from the chocolate agar is inoculated onto NA. 
Commercial X, V and XV factor discs are placed onto the plate and incubated at 
37°C in CO2 enriched incubator for 18-24 hours. H. influenzae will grow around the 
XV factor only. 
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1.4.1.2.2.2 Catalase test 
Catalase is present only in viable cultures so colony growth must be carried out for 
18 to 24 hours culture. Positive catalase results are shown by vigorous bubbling 
which indicates the presence of catalase. 
1.4.1.2.3 Serotyping 
Serotyping can differentiate between typeable strains (a to f) by using slide 
agglutination. However, this method is not applicable for non-typeable strains. 
Specific antisera can distinguish each strain due to different antibodies reaction with 
different somatic antigens. To perform this technique, one drop of normal saline is 
placed on a slide. The colony of H. influenzae is mixed thoroughly to reach 
homogenous suspension form. Then, one drop of specific antiserum is added and 
mixed thoroughly (CDC, 1998). Visible agglutination within one minute observation 
indicates a positive reaction.    
1.4.1.2.4 Antigen detection 
Antigen detection is more sensitive compared to culture method since it relies on 
antigen rather than viable bacteria. Latex agglutination is a rapid and sensitive 
method used to detect Hib capsular polysaccharide antigen in CSF, serum, urine, 
pleural fluid or joint. 
1.4.1.2.5    Antimicrobial susceptibility testing 
All H. influenzae isolates should be tested against a selected group of antimicrobial 
disk by using the disk diffusion and antibiotic gradient strip (E-test) testing methods. 
Disk diffusion provides the information on whether a strain is susceptible, 
intermediate or resistant. On the other hand, E-test provides the information on the 
MIC value of an antimicrobial agent. 
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1.4.2 Molecular methods 
PCR is a great tool for identification of bacteria because it can amplify the target 
DNA through repeated cycles of DNA denaturation, annealing of the primer to the 
DNA and extension steps (Kalle et al., 2014). Therefore, the detection of bacteria 
from clinical samples becomes easier even though the bacteria are nonviable due to 
inappropriate storage, transportation, condition and antibiotic treatment. Currently, 
the simplicity of this assay has made PCR the most common technique used in 
molecular biology. This assay allows rapid detection and quantification of bacteria 
due to its speed, sensitivity and simplicity of use (Caliendo et al., 2013). 
 
1.4.2.1 Monoplex PCR 
Conventional PCR such as monoplex PCR is a technique where a single target 
sequence is amplified from a single DNA template by using a single primer set 
(Kalle et al., 2014). The conventional PCR assay has been developed for detection of 
bacterial and viral pathogens with high sensitivity and specificity. The detection of 
K. pneumoniae carbapenemase (KPC) using PCR for rapid screening in an isolated 
hospital in Malaysia has been reported (Izzati et al., 2014). Rapid detection to 
identify the emergence of this pathogen is important in order to reduce detection time 
as compared to culture time. A PCR technique using colonies can give results within 
four to six hours, with excellent sensitivity and specificity (Hrabak et al., 2014). 
Many monoplex PCR assays are used to detect all of the families and subgroups 
associated with the family of beta- lactamase in K. pneumoniae (Queenan and Bush, 
2007). Sensitive and rapid PCR techniques have been reported for the identification 
of H. influenzae. The application of PCR for rapid detection of H. influenzae in 
pneumonia patients has been developed by Abdeldaim and co-workers (2009). The 
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etiology of pneumonia among young children has been evaluated by the detection of 
Hib using PCR method (Hassan-King et al., 1998). Moreover, the application of 
PCR is also being used for detection of meningitis incidence in Asia (Kennedy et al., 
2007). 
1.4.2.2 Multiplex PCR 
The conventional monoplex PCR has its limitation because it only provides the 
detection of single bacteria. Thus, this approach has been upgraded to allow 
immediate and simultaneous detection of several target genes in a single assay. 
Multiplex PCR amplifies two or more target DNAs using multiple sets of primers 
and is broadly used for detection and identification of K. pneumoniae and H. 
influenzae.   Stralin et al. (2006) reported that multiplex PCR has been developed to 
identify bacterial pathogen in bronchoalveolar lavage that affects adult patients with 
lower respiratory tract infection (LRTI). Moreover, multiplex PCR has been used for 
detection of URTI, LRTI and meningitis caused by H. influenzae, S. pneumoniae, M. 
Catarrhalis and N. meningitidis (Post et al., 1996; Tzanakaki et al., 2005; Abdeldaim 
et al., 2010).  Most of the multiplex PCR developed describe the detection and 
identification of three common pathogens associated with meningitis and RTI. 
Multiplex PCR is also used to differentiate between H. influenzae and H. 
parainfluenzae in nasopharyngeal swabs among healthy children in Taiwan (Tian et 
al., 2012). Ghasemi et al. (2013) developed a multiplex PCR approach for the 
identification of three genes associated with ESBL producing K. pneumoniae in ICU. 
Moreover, due to the emerging global implication of K. pneumoniae carbapenemase 
(KPC), Chen et al. (2014) has developed a multiplex PCR to distinguish between the 
two capsule polysaccharides causing diseases. 
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1.4.2.3 Real-time PCR 
The advent of new technologies such as real time PCR and microarray are becoming 
significant in this era. These approaches provide faster speed and greater sensitivity 
in the identification of bacteria. Detection of H. influenzae and S. pneumoniae by 
real-time PCR has been developed to increase the chances of detection rate and the 
accuracy of quantification (Corless et al., 2001; Selva et al., 2013). Kurupati and co-
workers (2004) reported the detection of K. pneumoniae from blood culture bottles 
using real time multiplex PCR. Only one study on multiplex PCR of K. pneumoniae 
and H. influenzae has been reported to detect multiple respiratory pathogens by using 
microarray (Shen et al., 2015). However, the application of these methods as 
diagnostic tools is challenging due to increasing costs, instruments availability, lack 
of access in the rural area, and lack of qualified trainer to perform these techniques 
(Espy et al., 2006). 
 
1.5  Treatments 
1.5.1 K. pneumoniae 
The rise of antibiotic-resistant strains of K. pneumoniae has made this pathogen 
difficult to treat. Some Klebsiella organisms are resistant towards multiple antibiotics 
including carbapenems which is known as the last drug option. Infections caused by 
KPC-producing bacteria can be difficult to treat because fewer antibiotics are 
effective against them. Clinicians are dependent on polymyxins and tigecycline for 
treatments. However, they are used irregularly due to their association with 
nephrotoxicity and neurotoxicity. Moreover, since more strains of Klebsiella spp. 
appear to develop and produce ESBLs, current antibiotics resistant seem to be 
increasing. These strains seem to be resistant towards carbenicillin, amoxicillin and 
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ceftazidime. However, ESBL can confer resistance to the third generation of 
cephalosporins such as cefotaxime, ceftriaxone and ceftazidime. A study from Lim et 
al. (2009) reported that majority of the K. pneumoniae strains which are resistant to 
more than three classes of antibiotics are susceptible towards imipenem.  
 
The initial antibiotic selection for patients infected by K. pneumoniae 
depends on the local susceptibility patterns of causing bacteremia. Klebsiella 
infections that are susceptible can be treated using cephalosporin, carbapenems, 
aminoglycosides and quinolones (CDC, 2012). Severely ill patients diagnosed for 
bacteremia should be treated with a combination of aminoglycosides and 
cephalosporin. The combination of both antibiotics showed greater result compared 
to monotherapy antibiotic (Feldman et al., 1990). Monotherapy treatment is likely to 
be effective against uncomplicated UTI. The usage of trimethoprim-
sulfamethoxazole, trimethoprim alone, ofloxacin, nitrofurantoin, norfloxacin was 
found to be successful for the treatment of UTI patients. In the absence of ESBL 
production, cephalosporins would be the effective drug to treat meningitis (Paterson 
et al., 2010). 
 
1.5.2  H. influenzae 
The treatment of H. influenzae is usually straightforward since this pathogen is 
sensitive towards most antibiotics (King, 2012). H. influenzae infection is regularly 
susceptible to a few antibiotics such as ceftriaxone, ampicillin, chloramphenicol and 
tetracyclines. Among cephalosporins, compounds such as cefuroxime, cefotaxime 
and ceftriaxone are highly sensitive. Penicillins are useful for the treatment of 
mucosal infections caused by non-typeable H. influenzae. The choice of antibiotic 
24 
  
and the length of treatment depend on the severity and the site of the infection. 
Usually, the treatment process of a patient infected by Hib takes up to ten days. 
Sometimes, cases associated with invasive disease which require hospitalization are 
best treated with the third-generation cephalosporin (CDC, 2015). 
 
The first choice of antibiotic treatment for meningitis patients is ceftriaxone 
or cefotaxime which must be given intravenously. It is highly effective because these 
antibiotics are bactericidal for H. influenzae. For patients with meningitis who are 
older than two months old, dexamethasone is an effective treatment as it has been 
shown to decrease the rate of hearing loss and inflammatory response. Moreover, 
dexamethasone decreases the risk of mortality and neurologic of patients with 
community acquired meningitis. First-generation cephalosporins, such as cephalexin, 
cephradine and cefadroxil are used for treatment of lower respiratory tract infections 
and are considered powerful. However, with the increasing activity against H. 
influenzae, the treatment has been changed to the third generation of cephalosporins 
(Duke et al., 2003). 
 
As for epiglottis treatment, an artificial airway such as breathing tube is 
inserted into the windpipe. Administered antibiotics such as ceftriaxone and 
cefuroxime are given once the airway is secured. Other infections due to non-
typeable H. influenzae can cause mucosal infections and can be treated with oral 
antibiotics. These include amoxilin (otitis media) and erythromycin (conjunctivitis). 
The treatment is switched to the usage of amoxicillin-clavulanate if the bacteria 
produce beta-lactamase. The duration of therapy for this disease is ten days 
(Pichichero, 2000) 
